Last 12 months
Inside the activity.
0 purchase rows · 35 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 7 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 12 |
| Jun 2026 | 0 | 14 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 04, 2026 Filed Mar 6, 2026 23:09 UTC |
Thorndike William N JrDirector
|
SaleCommon Stock | 125,000 | $24.26 | $3,032,500.00 |
DisclosureSEC source: 0001437827-26-000004 · wk-form4_1772838561.xml · nonDerivative · entry 1 Thorndike William N Jr · CIK 0001437827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,060,656 F1 · price: Represents the weighted average price of the shares sold on March 4, 2026. The prices of the shares sold pursuant to the transaction ranged from approximately $23.85 to $24.53 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:03 UTC |
Cool Tracy BrittDirector
|
GrantCommon Stock | 65,843 | $0.00 | $0.00 |
DisclosureSEC source: 0001646517-26-000006 · wk-form4_1772755409.xml · nonDerivative · entry 1 Cool Tracy Britt · CIK 0001646517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 250,493 F1 · kind: Represents an exempt acquisition from the issuer pursuant to Rule 16b-3(d) based on the Reporting Person's membership interests in EverArc Founders, LLC. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:02 UTC |
Raj VivekDirector
|
GrantCommon Stock | 555,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001708641-26-000004 · wk-form4_1772755373.xml · nonDerivative · entry 1 Raj Vivek · CIK 0001708641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 677,560 F1 · kind: Represents an exempt acquisition from the issuer pursuant to Rule 16b-3(d) based on the Reporting Person's membership interests in EverArc Founders, LLC. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:03 UTC |
Thorndike William N JrDirector
|
GrantCommon Stock | 5,582,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001437827-26-000002 · wk-form4_1772755396.xml · nonDerivative · entry 1 Thorndike William N Jr · CIK 0001437827 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,185,656 F1 · kind: Represents an exempt acquisition from the issuer pursuant to Rule 16b-3(d) based on the Reporting Person's membership interests in EverArc Founders, LLC. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:02 UTC |
Howley W NicholasDirector
|
GiftCommon Stock | 1,101,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001352573-26-000002 · wk-form4_1772755360.xml · nonDerivative · entry 2 Howley W Nicholas · CIK 0001352573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,086,840 F2 · kind: The Reporting Person gifted these shares to a 501(c)(3) nonprofit organization in an exempt transaction pursuant to Rule 16b-5. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:02 UTC |
Howley W NicholasDirector
|
GrantCommon Stock | 5,582,492 | $0.00 | $0.00 |
DisclosureSEC source: 0001352573-26-000002 · wk-form4_1772755360.xml · nonDerivative · entry 1 Howley W Nicholas · CIK 0001352573 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,188,692 F1 · kind: Represents an exempt acquisition from the issuer pursuant to Rule 16b-3(d) based on the Reporting Person's membership interests in EverArc Founders, LLC. Read SEC document |
| March 03, 2026 Filed Mar 6, 2026 00:02 UTC |
Khouri HaithamDirector · Chief Executive Officer
|
GrantCommon Stock | 1,600,317 | $0.00 | $0.00 |
DisclosureSEC source: 0001892618-26-000004 · wk-form4_1772755343.xml · nonDerivative · entry 1 Khouri Haitham · CIK 0001892618 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,104,150 F1 · kind: Represents an exempt acquisition from the issuer pursuant to Rule 16b-3(d) based on the Reporting Person's membership interests in EverArc Founders, LLC. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 17:30 UTC |
Bowman GrantPresident, Specialty Products
|
GrantStock Option (right to buy) · Derivative | 39,820 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0002040223-26-000002 · wk-form4_1772490619.xml · derivative · entry 2 Bowman Grant · CIK 0002040223 · President, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 39,820 Underlying: Common Stock · 39,820 shares Expires 2035-02-12 F2 · shares: On February 12, 2025, the reporting person was granted an option to purchase 225,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 39,820 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 17:30 UTC |
Bowman GrantPresident, Specialty Products
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0002040223-26-000002 · wk-form4_1772490619.xml · derivative · entry 1 Bowman Grant · CIK 0002040223 · President, Specialty Products 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2034-02-14 F1 · shares: On February 14, 2024, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 100,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:29 UTC |
Sable KyleChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $8.36 | $0.00 |
DisclosureSEC source: 0002001580-26-000002 · wk-form4_1772490563.xml · derivative · entry 3 Sable Kyle · CIK 0002001580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 300,000 Underlying: Common Stock · 100,000 shares Expires 2032-05-06 F3 · shares: On May 6, 2022, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 100,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:29 UTC |
Sable KyleChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 20,000 | $0.00 Strike: $3.89 | $0.00 |
DisclosureSEC source: 0002001580-26-000002 · wk-form4_1772490563.xml · derivative · entry 2 Sable Kyle · CIK 0002001580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 20,000 shares Expires 2033-11-16 F2 · shares: On November 16, 2023, the reporting person was granted an option to purchase 100,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 20,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:29 UTC |
Sable KyleChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 50,000 | $0.00 Strike: $13.24 | $0.00 |
DisclosureSEC source: 0002001580-26-000002 · wk-form4_1772490563.xml · derivative · entry 1 Sable Kyle · CIK 0002001580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 50,000 shares Expires 2034-09-27 F1 · shares: On September 27, 2024, the reporting person was granted an option to purchase 250,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 50,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Iversen Bernt G IIDirector
|
GrantStock Option (right to buy) · Derivative | 5,833 | $0.00 Strike: $10.13 | $0.00 |
DisclosureSEC source: 0001366888-26-000002 · wk-form4_1772490637.xml · derivative · entry 6 Iversen Bernt G II · CIK 0001366888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,333 Underlying: Common Stock · 5,833 shares Expires 2032-05-03 F6 · shares: On May 3, 2022, the reporting person was granted an option to purchase 29,167 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 5,833 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Iversen Bernt G IIDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001366888-26-000002 · wk-form4_1772490637.xml · derivative · entry 5 Iversen Bernt G II · CIK 0001366888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-09-06 F5 · shares: On September 6, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Iversen Bernt G IIDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001366888-26-000002 · wk-form4_1772490637.xml · derivative · entry 4 Iversen Bernt G II · CIK 0001366888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-02-15 F4 · shares: On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Iversen Bernt G IIDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001366888-26-000002 · wk-form4_1772490637.xml · derivative · entry 3 Iversen Bernt G II · CIK 0001366888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 7,000 shares Expires 2034-02-14 F3 · shares: On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Iversen Bernt G IIDirector
|
GrantStock Option (right to buy) · Derivative | 6,194 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001366888-26-000002 · wk-form4_1772490637.xml · derivative · entry 2 Iversen Bernt G II · CIK 0001366888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,194 Underlying: Common Stock · 6,194 shares Expires 2035-02-12 F2 · shares: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Iversen Bernt G IIDirector
|
GrantStock Option (right to buy) · Derivative | 2,655 | $0.00 Strike: $27.84 | $0.00 |
DisclosureSEC source: 0001366888-26-000002 · wk-form4_1772490637.xml · derivative · entry 1 Iversen Bernt G II · CIK 0001366888 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,655 Underlying: Common Stock · 2,655 shares Expires 2035-12-23 F1 · shares: On December 23, 2025, the reporting person was granted an option to purchase 15,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 2,655 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Khouri HaithamDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001892618-26-000002 · wk-form4_1772490600.xml · derivative · entry 3 Khouri Haitham · CIK 0001892618 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,200,000 Underlying: Common Stock · 400,000 shares Expires 2033-03-08 F3 · shares: On March 8, 2023, the reporting person was granted an option to purchase 2,000,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 400,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Khouri HaithamDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001892618-26-000002 · wk-form4_1772490600.xml · derivative · entry 2 Khouri Haitham · CIK 0001892618 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2034-02-14 F2 · shares: On February 14, 2024, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2026, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 100,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:30 UTC |
Khouri HaithamDirector · Chief Executive Officer
|
GrantStock Option (right to buy) · Derivative | 88,489 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001892618-26-000002 · wk-form4_1772490600.xml · derivative · entry 1 Khouri Haitham · CIK 0001892618 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,489 Underlying: Common Stock · 88,489 shares Expires 2035-02-12 F1 · shares: On February 12, 2025, the reporting person was granted an option to purchase 500,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 88,489 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:29 UTC |
Emery JeffreyPresident - Global Fire Safety
|
GrantStock Option (right to buy) · Derivative | 200,000 | $0.00 Strike: $8.36 | $0.00 |
DisclosureSEC source: 0001926809-26-000002 · wk-form4_1772490582.xml · derivative · entry 1 Emery Jeffrey · CIK 0001926809 · President - Global Fire Safety 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 200,000 shares Expires 2032-05-06 F1 · shares: On May 6, 2022, the reporting person was granted an option to purchase 1,000,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 200,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:29 UTC |
Yokozuka NorikoGeneral Counsel
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001892197-26-000002 · wk-form4_1772490547.xml · derivative · entry 1 Yokozuka Noriko · CIK 0001892197 · General Counsel 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 360,000 Underlying: Common Stock · 120,000 shares Expires 2031-11-08 F1 · shares: On November 8, 2021, the reporting person was granted an option to purchase 600,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 120,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
HENNESSY SEAN PDirector
|
GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001203507-26-000002 · wk-form4_1772490528.xml · derivative · entry 6 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,750 shares Expires 2031-12-07 F6 · shares: On December 7, 2021, the reporting person was granted an option to purchase 8,750 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 1,750 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
HENNESSY SEAN PDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $12.09 | $0.00 |
DisclosureSEC source: 0001203507-26-000002 · wk-form4_1772490528.xml · derivative · entry 5 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 7,000 shares Expires 2032-01-28 F5 · shares: On January 28, 2022, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
HENNESSY SEAN PDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001203507-26-000002 · wk-form4_1772490528.xml · derivative · entry 4 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-02-15 F4 · shares: On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
HENNESSY SEAN PDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001203507-26-000002 · wk-form4_1772490528.xml · derivative · entry 3 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-09-06 F3 · shares: On September 6, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
HENNESSY SEAN PDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001203507-26-000002 · wk-form4_1772490528.xml · derivative · entry 2 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 7,000 shares Expires 2034-02-14 F2 · shares: On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
HENNESSY SEAN PDirector
|
GrantStock Option (right to buy) · Derivative | 6,194 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001203507-26-000002 · wk-form4_1772490528.xml · derivative · entry 1 HENNESSY SEAN P · CIK 0001203507 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,194 Underlying: Common Stock · 6,194 shares Expires 2035-02-12 F1 · shares: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Henderson Robert SDirector
|
GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001352561-26-000002 · wk-form4_1772490512.xml · derivative · entry 7 Henderson Robert S · CIK 0001352561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,750 shares Expires 2031-12-07 F7 · shares: On December 7, 2021, the reporting person was granted an option to purchase 8,750 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 1,750 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Henderson Robert SDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $12.09 | $0.00 |
DisclosureSEC source: 0001352561-26-000002 · wk-form4_1772490512.xml · derivative · entry 6 Henderson Robert S · CIK 0001352561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 7,000 shares Expires 2032-01-28 F6 · shares: On January 28, 2022, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Henderson Robert SDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001352561-26-000002 · wk-form4_1772490512.xml · derivative · entry 5 Henderson Robert S · CIK 0001352561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-02-15 F5 · shares: On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Henderson Robert SDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.50 | $0.00 |
DisclosureSEC source: 0001352561-26-000002 · wk-form4_1772490512.xml · derivative · entry 4 Henderson Robert S · CIK 0001352561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-09-06 F4 · shares: On September 6, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Henderson Robert SDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001352561-26-000002 · wk-form4_1772490512.xml · derivative · entry 3 Henderson Robert S · CIK 0001352561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 7,000 shares Expires 2034-02-14 F3 · shares: On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Henderson Robert SDirector
|
GrantStock Option (right to buy) · Derivative | 6,194 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001352561-26-000002 · wk-form4_1772490512.xml · derivative · entry 2 Henderson Robert S · CIK 0001352561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,194 Underlying: Common Stock · 6,194 shares Expires 2035-02-12 F2 · shares: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Henderson Robert SDirector
|
GrantStock Option (right to buy) · Derivative | 2,655 | $0.00 Strike: $27.84 | $0.00 |
DisclosureSEC source: 0001352561-26-000002 · wk-form4_1772490512.xml · derivative · entry 1 Henderson Robert S · CIK 0001352561 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,655 Underlying: Common Stock · 2,655 shares Expires 2035-12-23 F1 · shares: On December 23, 2025, the reporting person was granted an option to purchase 15,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 2,655 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Cool Tracy BrittDirector
|
GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001646517-26-000004 · wk-form4_1772490491.xml · derivative · entry 5 Cool Tracy Britt · CIK 0001646517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,750 shares Expires 2031-12-07 F5 · shares: On December 7, 2021, the reporting person was granted an option to purchase 8,750 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 1,750 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Cool Tracy BrittDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $12.09 | $0.00 |
DisclosureSEC source: 0001646517-26-000004 · wk-form4_1772490491.xml · derivative · entry 4 Cool Tracy Britt · CIK 0001646517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 7,000 shares Expires 2032-01-28 F4 · shares: On January 28, 2022, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Cool Tracy BrittDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001646517-26-000004 · wk-form4_1772490491.xml · derivative · entry 3 Cool Tracy Britt · CIK 0001646517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-02-15 F3 · shares: On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Cool Tracy BrittDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001646517-26-000004 · wk-form4_1772490491.xml · derivative · entry 2 Cool Tracy Britt · CIK 0001646517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 7,000 shares Expires 2034-02-14 F2 · shares: On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:28 UTC |
Cool Tracy BrittDirector
|
GrantStock Option (right to buy) · Derivative | 6,194 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001646517-26-000004 · wk-form4_1772490491.xml · derivative · entry 1 Cool Tracy Britt · CIK 0001646517 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,194 Underlying: Common Stock · 6,194 shares Expires 2035-02-12 F1 · shares: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:27 UTC |
Raj VivekDirector
|
GrantStock Option (right to buy) · Derivative | 1,750 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001708641-26-000002 · wk-form4_1772490439.xml · derivative · entry 5 Raj Vivek · CIK 0001708641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,000 Underlying: Common Stock · 1,750 shares Expires 2031-12-07 F5 · shares: On December 7, 2021, the reporting person was granted an option to purchase 8,750 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 1,750 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:27 UTC |
Raj VivekDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $12.09 | $0.00 |
DisclosureSEC source: 0001708641-26-000002 · wk-form4_1772490439.xml · derivative · entry 4 Raj Vivek · CIK 0001708641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 7,000 shares Expires 2032-01-28 F4 · shares: On January 28, 2022, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2022, 2023, 2024, 2025 and 2026. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:27 UTC |
Raj VivekDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $8.88 | $0.00 |
DisclosureSEC source: 0001708641-26-000002 · wk-form4_1772490439.xml · derivative · entry 3 Raj Vivek · CIK 0001708641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 21,000 Underlying: Common Stock · 7,000 shares Expires 2033-02-15 F3 · shares: On February 15, 2023, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2023, 2024, 2025, 2026 and 2027. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:27 UTC |
Raj VivekDirector
|
GrantStock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $5.23 | $0.00 |
DisclosureSEC source: 0001708641-26-000002 · wk-form4_1772490439.xml · derivative · entry 2 Raj Vivek · CIK 0001708641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 7,000 shares Expires 2034-02-14 F2 · shares: On February 14, 2024, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2024, 2025, 2026, 2027 and 2028. The performance criteria for 2025 were met, resulting in the vesting of the option as to 7,000 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:27 UTC |
Raj VivekDirector
|
GrantStock Option (right to buy) · Derivative | 6,194 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001708641-26-000002 · wk-form4_1772490439.xml · derivative · entry 1 Raj Vivek · CIK 0001708641 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,194 Underlying: Common Stock · 6,194 shares Expires 2035-02-12 F1 · shares: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:27 UTC |
Valladares III Jorge L.Director
|
GrantStock Option (right to buy) · Derivative | 6,194 | $0.00 Strike: $11.80 | $0.00 |
DisclosureSEC source: 0001432892-26-000002 · wk-form4_1772490419.xml · derivative · entry 2 Valladares III Jorge L. · CIK 0001432892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,194 Underlying: Common Stock · 6,194 shares Expires 2035-02-12 F2 · shares: On February 12, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. Read SEC document |
| February 26, 2026 Filed Mar 2, 2026 22:27 UTC |
Valladares III Jorge L.Director
|
GrantStock Option (right to buy) · Derivative | 6,194 | $0.00 Strike: $9.67 | $0.00 |
DisclosureSEC source: 0001432892-26-000002 · wk-form4_1772490419.xml · derivative · entry 1 Valladares III Jorge L. · CIK 0001432892 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,194 Underlying: Common Stock · 6,194 shares Expires 2035-04-21 F1 · shares: On April 21, 2025, the reporting person was granted an option to purchase 35,000 shares of common stock. The option vests in five equal annual installments based on the Issuer's satisfaction of certain performance criteria for each of the fiscal years ending December 31, 2025, 2026, 2027, 2028 and 2029. The performance criteria for 2025 were partially met, resulting in the vesting of the option as to 6,194 shares of common stock. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:15 UTC |
Sable KyleChief Financial Officer
|
Exercise / conversionStock Option (right to buy) · Derivative | 100,000 | $0.00 Strike: $8.36 | $0.00 |
DisclosureSEC source: 0002001580-25-000004 · wk-form4_1765923312.xml · derivative · entry 3 Sable Kyle · CIK 0002001580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 200,000 Underlying: Common Stock · 100,000 shares Expires 2032-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 12, 2025 Filed Dec 16, 2025 22:15 UTC |
Sable KyleChief Financial Officer
|
SaleCommon Stock | 100,000 | $28.47 | $2,847,000.00 |
DisclosureSEC source: 0002001580-25-000004 · wk-form4_1765923312.xml · nonDerivative · entry 2 Sable Kyle · CIK 0002001580 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · price: Represents the weighted average price of the shares sold. The prices of the shares sold pursuant to the transaction ranged from approximately $28.16 to $29.44 per share. The Reporting Person, upon request, will provide the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.